Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Bionor Pharma ASA - Mandatory notification of trade

Bionor Pharma ASA
Posted on: 19 Sep 16



Lars Høie has on 19 September 2016 disposed of 20,000,000 subscription rights obtained in connection with the rights offering in Bionor Pharma ASA (the "Company"). After the transaction Lars Høie holds 97,699,303 subscription rights.

Lars Høie also holds 50,253,370 shares equivalent to 5.84% of the issued shares of the Company. Lars Høie further owns 15,253,370 warrants in the Company. His total holding of shares and warrants equals 7.61%, and his total holding of shares, warrants and subscription rights equals 18.96%, based on the registered share capital as of today.

This information is subject to the disclosure requirements set out in section 4-3 of the Norwegian Securities Trading Act.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Bionor Pharma ASA via GlobeNewswire

Last updated on: 21/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.